CAS: 176199-48-7 - (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid
Fórmula:C8H11NO4
InChI:InChI=1S/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1
Clave InChI:InChIKey=VTAARTQTOOYTES-RGDLXGNYSA-N
SMILES:O=C(O)C1C2CCC(N)(C(=O)O)C12
- Sinónimos:
- (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid
- (1S,2S,5R,6S)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid
- (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acidLY354740
- Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)-
- Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, [1S-(1α,2β,5α,6α)]-
- Eglumegad
- Eglumegad [INN]
- Eglumetad
- Ly 354740
- Ly354740
- Ver más sinónimos
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Eglumegad REF: TM-T15817CAS: 176199-48-7 | - - - | 67,00 € | Mar 21 Ene 25 | |
Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)- REF: IN-DA0024GKCAS: 176199-48-7 | 99.88% | A consultar | Mié 22 Ene 25 | |
LY 354740 REF: 3D-BL162676CAS: 176199-48-7 | Min. 95% | 338,00 €~1.938,00 € | Mié 05 Mar 25 |
Eglumegad
CAS:176199-48-7
Eglumegad is a highly effective and selective agonist of group II (mGlu2/3) receptor (IC50s: 5 …
Fórmula:
C8H11NO4
Forma y color:
Solid
Peso molecular:
185.18
Ref: TM-T15817
1mg | 67,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)-
CAS:176199-48-7
Fórmula:
C8H11NO4
Pureza:
99.88%
Forma y color:
Solid
Peso molecular:
185.1772
Ref: IN-DA0024GK
5mg | 261,00 € | ||
10mg | 485,00 € | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 22 de Enero de 2025
LY 354740
CAS:176199-48-7
Metabotropic glutamate receptor (mGluR2/3) agonist
Fórmula:
C8H11NO4
Pureza:
Min. 95%
Peso molecular:
185.18 g/mol
Ref: 3D-BL162676
5mg | 338,00 € | ||
10mg | 494,00 € | ||
25mg | 837,00 € | ||
50mg | 1.169,00 € | ||
100mg | 1.938,00 € |
Entrega estimada en Estados Unidos, el Miércoles 5 de Marzo de 2025